IMLE Financials 07/16/2014 10:15:02 TransBiotec,

IMLE Financials 07/16/2014 10:15:02
TransBiotec, Inc.
Period Ending Dec 31, 2013 Dec 31, 2012 Dec 31, 2011 Dec 31, 2010
Total Revenue - - - -
Cost of Revenue - - - -
Gross Profit - - - -
Operating Expenses
Research and Development - - - -
Sales, General and Admin. 784 2,887 637 242
Non-Recurring Items - - - -
Other 1 1 1 7
Operating Income (785) (2,887) (638) (250)
Income From Continuing Operations
Add'l Income/Expense Items 286 (443) - -
Earnings Before Interest and Tax (499) (3,331) (638) (250)
Interest Expense 265 230 544 249
Earnings Before Tax (763) (3,561) (1,182) (498)
Income Tax - - - -
Minority Interest (5) ( (81) -
Equity Earnings Unconsolidated Subsidiary - - - -
Net Income Cont. Operations (659) (3,553) (1,101) (498)
Non Recurring Events
Discontinued Operations - - - -
Extraordinary Items - - - -
Effect of Accounting Changes - - - -
Other Items - - - -
Net Income (758) (3,553) (1,101) (498)
Preferred Stock and Other Adjustments - - - -
Net Income Applicable to Common Shareholders (758) (3,553) (1,101) (498)